GEN
Overvalued by 22.5% based on the discounted cash flow analysis.
Market cap | $15.39 Billion |
---|---|
Enterprise Value | $23.15 Billion |
Dividend Yield | $0.4919 (2.0%) |
Earnings per Share | $0.96 |
Beta | 1.05 |
Outstanding Shares | 626,145,897 |
Avg 30 Day Volume | 6,295,247 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 24.98 |
---|---|
PEG | -29.27 |
Price to Sales | 4.14 |
Price to Book Ratio | 8.28 |
Enterprise Value to Revenue | 6.07 |
Enterprise Value to EBIT | 19.63 |
Enterprise Value to Net Income | 37 |
Total Debt to Enterprise | 0.37 |
Debt to Equity | 3.92 |
No data
No data